These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1409439)

  • 1. The shift from physiological genetics to molecular genetics in the study of mouse tyrosinase.
    Quevedo WC; Holstein TJ
    Pigment Cell Res; 1992; Suppl 2():57-60. PubMed ID: 1409439
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular structure of the tyrosinase gene.
    Takeuchi T
    Pigment Cell Res; 1992; Suppl 2():61-6. PubMed ID: 1409440
    [No Abstract]   [Full Text] [Related]  

  • 3. The nature of tyrosinase isozymes.
    Tsukamoto K; Jiménez M; Hearing VJ
    Pigment Cell Res; 1992; Suppl 2():84-9. PubMed ID: 1409443
    [No Abstract]   [Full Text] [Related]  

  • 4. Recent advances in the molecular biology of pigmentation: mouse models.
    Halaban R; Moellmann G
    Pigment Cell Res; 1992; Suppl 2():67-78. PubMed ID: 1409441
    [No Abstract]   [Full Text] [Related]  

  • 5. The tyrosinase gene and oculocutaneous albinism type 1 (OCA1): A model for understanding the molecular biology of melanin formation.
    Oetting WS
    Pigment Cell Res; 2000 Oct; 13(5):320-5. PubMed ID: 11041207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse coat colour mutations: a molecular genetic resource which spans the centuries.
    Jackson IJ
    Bioessays; 1991 Sep; 13(9):439-46. PubMed ID: 1796906
    [No Abstract]   [Full Text] [Related]  

  • 7. Tyrosinase abundance and activity in murine hairbulb melanocytes of agouti mutants (C57BL/6J-a/a, Ay/a, and AwJ/AwJ).
    Kappenman KE; Dvoracek MA; Harvison GA; Fuller BB; Granholm NH
    Pigment Cell Res; 1992; Suppl 2():79-83. PubMed ID: 1409442
    [No Abstract]   [Full Text] [Related]  

  • 8. The molecular basis of type I (tyrosinase-deficient) human oculocutaneous albinism.
    Giebel LB; Spritz RA
    Pigment Cell Res; 1992; Suppl 2():101-6. PubMed ID: 1409411
    [No Abstract]   [Full Text] [Related]  

  • 9. Temperature-sensitive tyrosinase associated with peripheral pigmentation in oculocutaneous albinism.
    King RA; Townsend D; Oetting W; Summers CG; Olds DP; White JG; Spritz RA
    J Clin Invest; 1991 Mar; 87(3):1046-53. PubMed ID: 1900307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Human oculocutaneous albinism. From clinical observation to molecular biology].
    Aquaron R
    Bull Soc Pathol Exot; 1993; 86(5):313-26. PubMed ID: 8124097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosinase gene mutations causing oculocutaneous albinisms.
    Tomita Y
    J Invest Dermatol; 1993 Feb; 100(2 Suppl):186S-190S. PubMed ID: 8433007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of an extended family with type IA (tyrosinase-negative) oculocutaneous albinism.
    Oetting WS; Handoko HY; Mentink MM; Paller AS; White JG; King RA
    J Invest Dermatol; 1991 Jul; 97(1):15-9. PubMed ID: 1676041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dinucleotide deletion (-delta GA115) in the tyrosinase gene responsible for type I-A (tyrosinase negative) oculocutaneous albinism in a Pakistani individual.
    Oetting WS; Fryer JP; King RA
    Hum Mol Genet; 1993 Jul; 2(7):1047-8. PubMed ID: 8364542
    [No Abstract]   [Full Text] [Related]  

  • 14. Sequence analysis of tyrosinase gene in ocular and oculocutaneous albinism patients: introducing three novel mutations.
    Khordadpoor-Deilamani F; Akbari MT; Karimipoor M; Javadi G
    Mol Vis; 2015; 21():730-5. PubMed ID: 26167114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A transgenic mouse model with inducible Tyrosinase gene expression using the tetracycline (Tet-on) system allows regulated rescue of abnormal chiasmatic projections found in albinism.
    Giménez E; Lavado A; Giraldo P; Cozar P; Jeffery G; Montoliu L
    Pigment Cell Res; 2004 Aug; 17(4):363-70. PubMed ID: 15250938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of type IA (tyrosinase negative) oculocutaneous albinism.
    King RA; Oetting WS
    Pigment Cell Res; 1992; Suppl 2():249-53. PubMed ID: 1409426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A tyrosinase gene missense mutation in temperature-sensitive type I oculocutaneous albinism. A human homologue to the Siamese cat and the Himalayan mouse.
    Giebel LB; Tripathi RK; King RA; Spritz RA
    J Clin Invest; 1991 Mar; 87(3):1119-22. PubMed ID: 1900309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative genetics of albinism.
    Searle AG
    Ophthalmic Paediatr Genet; 1990 Sep; 11(3):159-64. PubMed ID: 2126367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-random distribution of missense mutations within the human tyrosinase gene in type I (tyrosinase-related) oculocutaneous albinism.
    King RA; Mentink MM; Oetting WS
    Mol Biol Med; 1991 Feb; 8(1):19-29. PubMed ID: 1943686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pink-eyed dilution gene and the molecular pathogenesis of tyrosinase-positive albinism (OCA2).
    Manga P; Orlow SJ
    J Dermatol; 1999 Nov; 26(11):738-47. PubMed ID: 10635616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.